Cargando…

Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018

Lassa fever (LF) is endemic to Nigeria, where the disease causes substantial rates of illness and death. In this article, we report an analysis of the epidemiologic and clinical aspects of the LF outbreak that occurred in Nigeria during January 1–May 6, 2018. A total of 1,893 cases were reported; 42...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilori, Elsie A., Furuse, Yuki, Ipadeola, Oladipupo B., Dan-Nwafor, Chioma C., Abubakar, Anwar, Womi-Eteng, Oboma E., Ogbaini-Emovon, Ephraim, Okogbenin, Sylvanus, Unigwe, Uche, Ogah, Emeka, Ayodeji, Olufemi, Abejegah, Chukwuyem, Liasu, Ahmed A., Musa, Emmanuel O., Woldetsadik, Solomon F., Lasuba, Clement L.P., Alemu, Wondimagegnehu, Ihekweazu, Chikwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537738/
https://www.ncbi.nlm.nih.gov/pubmed/31107222
http://dx.doi.org/10.3201/eid2506.181035
_version_ 1783422080780337152
author Ilori, Elsie A.
Furuse, Yuki
Ipadeola, Oladipupo B.
Dan-Nwafor, Chioma C.
Abubakar, Anwar
Womi-Eteng, Oboma E.
Ogbaini-Emovon, Ephraim
Okogbenin, Sylvanus
Unigwe, Uche
Ogah, Emeka
Ayodeji, Olufemi
Abejegah, Chukwuyem
Liasu, Ahmed A.
Musa, Emmanuel O.
Woldetsadik, Solomon F.
Lasuba, Clement L.P.
Alemu, Wondimagegnehu
Ihekweazu, Chikwe
author_facet Ilori, Elsie A.
Furuse, Yuki
Ipadeola, Oladipupo B.
Dan-Nwafor, Chioma C.
Abubakar, Anwar
Womi-Eteng, Oboma E.
Ogbaini-Emovon, Ephraim
Okogbenin, Sylvanus
Unigwe, Uche
Ogah, Emeka
Ayodeji, Olufemi
Abejegah, Chukwuyem
Liasu, Ahmed A.
Musa, Emmanuel O.
Woldetsadik, Solomon F.
Lasuba, Clement L.P.
Alemu, Wondimagegnehu
Ihekweazu, Chikwe
author_sort Ilori, Elsie A.
collection PubMed
description Lassa fever (LF) is endemic to Nigeria, where the disease causes substantial rates of illness and death. In this article, we report an analysis of the epidemiologic and clinical aspects of the LF outbreak that occurred in Nigeria during January 1–May 6, 2018. A total of 1,893 cases were reported; 423 were laboratory-confirmed cases, among which 106 deaths were recorded (case-fatality rate 25.1%). Among all confirmed cases, 37 occurred in healthcare workers. The secondary attack rate among 5,001 contacts was 0.56%. Most (80.6%) confirmed cases were reported from 3 states (Edo, Ondo, and Ebonyi). Fatal outcomes were significantly associated with being elderly; no administration of ribavirin; and the presence of a cough, hemorrhaging, and unconsciousness. The findings in this study should lead to further LF research and provide guidance to those preparing to respond to future outbreaks.
format Online
Article
Text
id pubmed-6537738
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-65377382019-06-05 Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018 Ilori, Elsie A. Furuse, Yuki Ipadeola, Oladipupo B. Dan-Nwafor, Chioma C. Abubakar, Anwar Womi-Eteng, Oboma E. Ogbaini-Emovon, Ephraim Okogbenin, Sylvanus Unigwe, Uche Ogah, Emeka Ayodeji, Olufemi Abejegah, Chukwuyem Liasu, Ahmed A. Musa, Emmanuel O. Woldetsadik, Solomon F. Lasuba, Clement L.P. Alemu, Wondimagegnehu Ihekweazu, Chikwe Emerg Infect Dis Synopsis Lassa fever (LF) is endemic to Nigeria, where the disease causes substantial rates of illness and death. In this article, we report an analysis of the epidemiologic and clinical aspects of the LF outbreak that occurred in Nigeria during January 1–May 6, 2018. A total of 1,893 cases were reported; 423 were laboratory-confirmed cases, among which 106 deaths were recorded (case-fatality rate 25.1%). Among all confirmed cases, 37 occurred in healthcare workers. The secondary attack rate among 5,001 contacts was 0.56%. Most (80.6%) confirmed cases were reported from 3 states (Edo, Ondo, and Ebonyi). Fatal outcomes were significantly associated with being elderly; no administration of ribavirin; and the presence of a cough, hemorrhaging, and unconsciousness. The findings in this study should lead to further LF research and provide guidance to those preparing to respond to future outbreaks. Centers for Disease Control and Prevention 2019-06 /pmc/articles/PMC6537738/ /pubmed/31107222 http://dx.doi.org/10.3201/eid2506.181035 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Ilori, Elsie A.
Furuse, Yuki
Ipadeola, Oladipupo B.
Dan-Nwafor, Chioma C.
Abubakar, Anwar
Womi-Eteng, Oboma E.
Ogbaini-Emovon, Ephraim
Okogbenin, Sylvanus
Unigwe, Uche
Ogah, Emeka
Ayodeji, Olufemi
Abejegah, Chukwuyem
Liasu, Ahmed A.
Musa, Emmanuel O.
Woldetsadik, Solomon F.
Lasuba, Clement L.P.
Alemu, Wondimagegnehu
Ihekweazu, Chikwe
Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
title Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
title_full Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
title_fullStr Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
title_full_unstemmed Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
title_short Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
title_sort epidemiologic and clinical features of lassa fever outbreak in nigeria, january 1–may 6, 2018
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537738/
https://www.ncbi.nlm.nih.gov/pubmed/31107222
http://dx.doi.org/10.3201/eid2506.181035
work_keys_str_mv AT ilorielsiea epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT furuseyuki epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT ipadeolaoladipupob epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT dannwaforchiomac epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT abubakaranwar epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT womietengobomae epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT ogbainiemovonephraim epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT okogbeninsylvanus epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT unigweuche epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT ogahemeka epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT ayodejiolufemi epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT abejegahchukwuyem epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT liasuahmeda epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT musaemmanuelo epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT woldetsadiksolomonf epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT lasubaclementlp epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT alemuwondimagegnehu epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT ihekweazuchikwe epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018
AT epidemiologicandclinicalfeaturesoflassafeveroutbreakinnigeriajanuary1may62018